Cambridge Nutritional Sciences (CNSL) Share Price, News & Analysis

Company Overview

Cambridge Nutritional Sciences plc (AIM: CNSL) is a specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition.

Key Stats

• Today's Range: 2.56 to 2.57
• 50-Day Range: 2.52 to 3.30
• 52-Week Range: 2.50 to 4.48
• Volume: 104,801 shs
• Average Volume: 365,369 shs
• Market Capitalization: £6.12 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CNSL Stock Analysis - Frequently Asked Questions

How have CNSL shares performed this year?

Cambridge Nutritional Sciences' stock was trading at GBX 2.80 on January 1st, 2025. Since then, CNSL stock has decreased by 8.1% and is now trading at GBX 2.57.
View the best growth stocks for 2025 here.

How were Cambridge Nutritional Sciences' earnings last quarter?

Cambridge Nutritional Sciences plc (LON:CNSL) issued its quarterly earnings data on Thursday, November, 21st. The company reported ($0.10) earnings per share (EPS) for the quarter. Cambridge Nutritional Sciences had a negative net margin of 3.36% and a negative trailing twelve-month return on equity of 3.34%.

How do I buy shares of Cambridge Nutritional Sciences?

Shares of CNSL stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Company Calendar

• Last Earnings: 11/21/2024
• Today: 4/24/2025

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Medical Instruments & Supplies
• Sub-Industry: Communication
• Current Symbol: LON:CNSL
• CIK: N/A
• Web: www.cnsplc.com
• Phone: (217) 235-3311
• Fax: N/A
• Employees: 3,200
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 74.27
• P/E Growth: N/A
• Net Income: £-3,030,000.00
• Net Margins: -3.36%
• Pretax Margin: N/A
• Return on Equity: -3.34%
• Return on Assets: -2.36%

Debt

• Debt-to-Equity Ratio: 1.53
• Current Ratio: 4.67
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: £9.77 million
• Price / Sales: 0.67
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: GBX 4 per share
• Price / Book: 0.68

Miscellaneous

• Outstanding Shares: 237,950,000
• Free Float: N/A
• Market Cap: £6.52 million
• Optionable: N/A
• Beta: 3.89